Evidence map›Paper›PMID 18550736›Full record

ArticleJournal of clinical microbiology2008

Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification.

Yuki Higashimoto, Masaru Ihira, Akane Ohta, Shigeki Inoue, Chie Usui, Yoshizo Asano, Tetsushi Yoshikawa

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuki HigashimotoDepartment of Clinical Immunology, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.
Masaru Ihira
Akane Ohta
Shigeki Inoue
Chie Usui
Yoshizo Asano
Tetsushi Yoshikawa
Fujita Health University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The loop-mediated isothermal amplification (LAMP) method was developed to distinguish between the varicella-zoster virus (VZV) vaccine (vOka) strain and wild-type strains. Two single nucleotide polymorphisms (SNPs) (nucleotide [nt] 105705 for VR-1 VZV LAMP and nt 106262 for VR-2 VZV LAMP) located in the open reading frame 62 gene were selected as LAMP targets. Amplified vOka DNA demonstrated a typical ladder pattern; however, no LAMP product was detected in reactions performed with DNAs from other human herpesviruses by either VR-1 VZV LAMP or VR-2 VZV LAMP. This result was confirmed by a turbidity assay. The sensitivities of both VR-1 and VR-2 VZV LAMP determined by either the turbidity assay or agarose gel electrophoresis were 100 copies per reaction. To discriminate the vOka strain from wild-type strains, VR-1 and VR-2 VZV LAMP products were digested with the appropriate restriction enzymes (SacII for VR-1 LAMP and SmaI for VR-2 LAMP). The digested products were clearly different in the vOka strain and wild-type strains. To evaluate the utility of the LAMP methods for rapid differentiation, viral DNA (without DNA extraction) in swab samples was directly tested. Wild-type VZV DNA was detected in 20 swab samples by either VR-1 VZV LAMP or VR-2 VZV LAMP. Sequence analysis confirmed the expected SNPs in the LAMP products amplified from the vOka strain and the five wild-type strains.

Indexed as

Chickenpox VaccineBase SequenceChickenpoxDeoxyribonucleases, Type II Site-SpecificDNA PrimersDNA, ViralElectrophoresis, Agar GelHerpesvirus 3, HumanHumansImmediate-Early ProteinsMolecular Sequence DataNephelometry and TurbidimetryNucleic Acid Amplification TechniquesPolymorphism, Single NucleotideSensitivity and SpecificityTrans-ActivatorsCCCGGG-specific type II deoxyribonucleasesCCGCGG-specific type II deoxyribonucleasesChickenpox VaccineDeoxyribonucleases, Type II Site-SpecificDNA PrimersDNA, ViralIE62 protein, Human herpesvirus 3Immediate-Early ProteinsTrans-ActivatorsViral Envelope Proteins

Identifiers

PMID18550736
PMCPMC2519472
OpenAlexW2162489505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.